Pharma News

Fujifilm Corporation is investing $40 million in Fujifilm Diosynth Biotechnologies, its Contract Development and Manufacturing Organization (CDMO), for a new factory in the Boston area, specif...

In the first week of the new year, two companies raised more than $150 million in separate Series A financing rounds to fund research programs aimed at developing treatments for cancer and rare diseas...

Researchers with Shenzhen Institutes of Advanced Technology in China used a variety of computational techniques to simulate drug-virus interactions.

It was reported yesterday that Operation Warp Speed, the Trump administration’s program to develop and distribute a COVID-19 vaccine, was considering cutting doses of the Moderna vaccine in order to...

The World Health Organization on Thursday granted emergency validation to the Pfizer-BioNTech vaccine, paving the way for countries worldwide to quickly approve its import and distribution.

In the past few decades, researchers have identified biological pathways leading to neurodegenerative diseases and developed promising molecular agents to target them.

The U.

One of America's most senior government officials says the most 'credible' theory about the origin of coronavirus is that it escaped from a laboratory in China.

SAN DIEGO, Dec.

GAITHERSBURG, Md.

Shares of Protalix Biotherapeutics were up nearly 7% in premarket trading after the company announced its Phase III BRIDGE study met key objectives in treating Fabry Disease.

Residents of the United Kingdom now have a second vaccine against the novel coronavirus, even as a more virulent strain of COVID-19 sweeps across its lands.